SKI Market

Indian Indices

Nifty

24,712.05 -255.70
(-1.02%)

Sensex

80,786.54 -849.37
( -1.04%)

Bank Nifty

54,450.45 -688.85
( -1.25%)

Nifty IT

36,063.20 -216.85
( -0.60%)

Global Indices

Nasdaq

45,450.55 147.07
(0.32%)

Dow Jones

6,488.44 28.12
(0.44%)

Hang Seng

42,514.95 120.55
(0.28%)

Nikkei 225

9,265.80 -55.60
(-0.60%)

Forex

USD-INR

87.51 0.16
(0.19%)

EUR-INR

102.17 -0.20
(-0.19%)

GBP-INR

118.05 -0.04
(-0.04%)

JPY-INR

0.59 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Oasis Securities Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

512489

INE876A01023

7.1460541

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

55.9

43.44

EPS(TTM)

Face Value()

Div & Yield %

0.42

Back

telecanor global ltd

Glenmark Pharmaceuticals consolidated net profit declines 86.23% in the June 2025 quarter

Aug 15,2025

Net profit of Glenmark Pharmaceuticals declined 86.23% to Rs 46.87 crore in the quarter ended June 2025 as against Rs 340.27 crore during the previous quarter ended June 2024. Sales declined 5.09% to Rs 3059.33 crore in the quarter ended June 2025 as against Rs 3223.30 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	3059.33	3223.30	-5
OPM %	18.98	18.25	-
PBDT	548.73	580.12	-5
PBT	418.81	462.33	-9
NP	46.87	340.27	-86

24,712.05 -255.70 (-1.02%)

80,786.54 -849.37 ( -1.04%)

54,450.45 -688.85 ( -1.25%)

36,063.20 -216.85 ( -0.60%)

45,450.55 147.07 (0.32%)

6,488.44 28.12 (0.44%)

42,514.95 120.55 (0.28%)

9,265.80 -55.60 (-0.60%)

87.51 0.16 (0.19%)

102.17 -0.20 (-0.19%)

118.05 -0.04 (-0.04%)

0.59 0.00 (-0.17%)